Y-Intercept (HK)’s Soleno Therapeutics SLNO Stock Holding History

Y-Intercept (HK)’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-47,731	Closed	-$1.6M	–	2129
2026 Q1	$1.6M	Buy	47,731 +21,046	+79%	+$825K	0.03%	820
2025 Q4	$1.24M	Buy	+26,685	New	+$1.46M	0.03%	879
2025 Q3	–	Sell	-5,594	Closed	-$469K	–	2003
2025 Q2	$469K	Sell	5,594 -34,831	-86%	-$2.61M	0.01%	1229
2025 Q1	$2.89M	Buy	+40,425	New	+$1.97M	0.2%	121
2021 Q3	–	Sell	-905	Closed	-$15K	–	886
2021 Q2	$15K	Buy	+905	New	+$15.3K	﹤0.01%	588

Y-Intercept (HK)'s SLNO Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 47,731 shares — an estimated $1.6M sold.

Y-Intercept (HK) first reported a position in SLNO in Q2 2021 and held it in 5 quarters. The position peaked at $2.89M in Q1 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Y-Intercept (HK) reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 47,731 Soleno Therapeutics shares in Q2 2026, an estimated $1.6M.
Y-Intercept (HK) first reported a position in Soleno Therapeutics in Q2 2021 and held it in 5 quarters.
Y-Intercept (HK)'s Soleno Therapeutics position peaked at $2.89M in Q1 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.